Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$83.83+1.73 (+2.11%)
Close on Nov 18, 2026Market cap $6.58BP/E –Yield –
Abivax market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Abivax's market cap was $7.30B on Nov 11, 2026, against $7.87B a year earlier. Over the last 3 years it ranged from $205.17M to $10.57B, with a median of $899.72M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.30B | -14.2% |
| 2025 | Dec 31, 2025 | $8.50B | +1746.1% |
| 2024 | Dec 31, 2024 | $460.56M | +93.0% |
| 2023 | Dec 29, 2023 | $238.62M | – |
See a number that looks wrong?